Rhumbline Advisers »

Aerovate Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $320k 14k 22.63
2023-09-30 $190k 14k 13.57
2023-06-30 $223k 13k 17.15
2023-03-31 $298k 15k 20.14
2022-12-31 $417k 14k 29.30
2022-09-30 $234k 14k 16.55
2022-06-30 $206k 13k 15.61